Hamburg Tries To “Cope” With FDA Budget, Pines For Predictability
This article was originally published in The Rose Sheet
Executive Summary
The commissioner says FDA cannot operate effectively without predictable budgets, just as industry needs consistent FDA policy and actions for successful drug development. Making sequestered user fees available could be accomplished in fiscal 2014 budget negotiations.
You may also be interested in...
FDA’s Hopes For User Fee Un-Sequestration Likely Hinge On Senate Appropriations Panel
House leadership plans a comprehensive bill to undo sequestration for the government as a whole, but Rep. Robert Aderholt, who chairs the House subcommittee that originates appropriations for FDA, says he is willing to work with Senate appropriators in conference on a fix specific to the agency’s user fees.
FDA Budget Faces $319 Million Cut Under Sequestration
The estimated reduction, included in the White House OMB’s report to Congress, is equal to the cost of 900 to 1,200 agency employees, an agency advocate says. The across-the-board cuts loom with the failure of the congressional Super Committee to find $1.2 trillion in cuts over 10 years.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.